Análisis de la utilidad de la vacuna Candid 1 en la prevención de la fiebre hemorrágica argentina en niños

Feuillade, María Rosa; Enría, Delia A.
Revista Panamericana de Salud Pública (OPS) = Pan American Journal of Public Health (PAHO) ; 18(2): 100-6, 2005.
Artículo en Español | PAHO | ID: pah-250315

Documentos relacionados

  1. Restoration of virulence in the attenuated Candid#1 vaccine virus requires reversion at both positions 168 and 427 in the envelope glycoprotein GPC.
  2. Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.
  3. Recent developments on Junin virus, a causative agent for Argentine haemorrhagic fever.
  4. Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity.
  5. Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junín Virus Infection in Guinea Pigs.
  6. Promyelocytic leukemia protein is a restriction factor for Junín virus independently of Z matrix protein.
  7. Potential and action mechanism of favipiravir as an antiviral against Junin virus.
  8. Differential Immune Responses to New World and Old World Mammalian Arenaviruses.
  9. [Phenotypic markers of attenuation in Junin virus strains recently isolated from individuals vaccinated with Junin Candid#1 strain].
  10. Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody.